Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma

Author:

Tai Wei-Tien¹²,Shiau Chung-Wai³,Chen Pei-Jer¹,Chu Pei-Yi⁴,Huang Hsiang-Po¹,Liu Chun-Yu³⁵,Huang Jui-Wen⁶,Chen Kuen-Feng¹²

Affiliation:

1. Department of Medical Research; National Taiwan University Hospital; Taipei 10055 Taiwan

2. National Center of Excellence for Clinical Trial and Research; National Taiwan University Hospital; Taipei 10055 Taiwan

3. Institute of Biopharmaceutical Sciences; National Yang-Ming University; Taipei 11221 Taiwan

4. Department of Pathology; St. Martin De Porres Hospital; Chiayi 60069 Taiwan

5. Division of Hematology and Oncology; Department of Medicine; Taipei Veterans General Hospital; Taipei 11221 Taiwan

6. Industrial Technology Research Institute; Hsin-Chu 31040 Taiwan

Publisher

Wiley

Subject

Hepatology

Link

Reference22 articles.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献